Biofil Financial Statements From 2010 to 2024

BIOFILCHEM   59.20  0.19  0.32%   
Biofil Chemicals financial statements provide useful quarterly and yearly information to potential Biofil Chemicals Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Biofil Chemicals financial statements helps investors assess Biofil Chemicals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Biofil Chemicals' valuation are summarized below:
Gross Profit
25.6 M
Profit Margin
0.0138
Market Capitalization
961.9 M
Enterprise Value Revenue
2.3863
Revenue
460.5 M
We have found seventy-eight available fundamental signals for Biofil Chemicals Pharmaceuticals, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of Biofil Chemicals' prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road.

Biofil Chemicals Total Revenue

420.37 Million

Check Biofil Chemicals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofil Chemicals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Interest Expense of 738.5 K or Total Revenue of 420.4 M, as well as many indicators such as . Biofil financial statements analysis is a perfect complement when working with Biofil Chemicals Valuation or Volatility modules.
  
This module can also supplement various Biofil Chemicals Technical models . Check out the analysis of Biofil Chemicals Correlation against competitors.

Biofil Chemicals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding16.7 M16.1 M22.3 M
Slightly volatile
Total Assets242.1 M470.8 M237.2 M
Slightly volatile
Short and Long Term Debt Total4.2 M4.4 M17.2 M
Slightly volatile
Total Current Liabilities299.5 M285.2 M126.3 M
Slightly volatile
Total Stockholder Equity119.5 M182 M118.3 M
Slightly volatile
Property Plant And Equipment Net99.3 M86.2 M92.1 M
Slightly volatile
Accounts Payable289.3 M275.5 M109 M
Slightly volatile
Cash24 M22.8 M4.9 M
Slightly volatile
Non Current Assets Total99.9 M86.8 M92.6 M
Slightly volatile
Cash And Short Term Investments24 M22.8 M4.9 M
Slightly volatile
Net Receivables346.8 M330.3 M141.6 M
Slightly volatile
Liabilities And Stockholders Equity242.1 M470.8 M237.2 M
Slightly volatile
Inventory26.8 M25.5 M11.6 M
Slightly volatile
Other Current Assets5.2 M5.5 M43.2 M
Very volatile
Total Liabilities303.2 M288.8 M130.9 M
Slightly volatile
Total Current Assets403.3 M384.1 M162 M
Slightly volatile
Common Stock171.2 M187.1 M161.1 M
Slightly volatile
Short Term Debt4.2 M4.4 M15.2 M
Slightly volatile
Accumulated Other Comprehensive Income258.5 M320.3 M210.4 M
Slightly volatile
Net Tangible Assets140 M193.6 M125.6 M
Slightly volatile
Short and Long Term Debt4.2 M4.4 M15.9 M
Slightly volatile
Property Plant Equipment103.6 M103.5 M95 M
Slightly volatile
Capital Surpluse13.8 M15.6 M16.9 M
Slightly volatile
Net Invested Capital182.9 M186.4 M158.5 M
Slightly volatile
Cash And Equivalents222.3 K234 K2.7 M
Slightly volatile
Net Working Capital71 M98.8 M53.1 M
Slightly volatile
Capital Stock130.2 M146.5 M159.5 M
Slightly volatile
Short Term Investments23 M21.9 M6.2 M
Slightly volatile
Property Plant And Equipment Gross127.2 M133.7 M116.9 M
Slightly volatile

Biofil Chemicals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.1 MM3.1 M
Slightly volatile
Total Revenue420.4 M400.4 M191.6 M
Slightly volatile
Gross Profit20.9 M12.5 M22.4 M
Slightly volatile
Other Operating Expenses402.6 M383.4 M182 M
Slightly volatile
Cost Of Revenue407.2 M387.8 M169.7 M
Slightly volatile
Total Operating Expenses13.7 M25.3 M15.4 M
Slightly volatile
Income Tax Expense1.9 M1.6 M2.1 M
Slightly volatile
Selling And Marketing Expenses110.2 K116 K1.4 M
Slightly volatile
Selling General AdministrativeM6.7 M2.6 M
Slightly volatile
Net Income From Continuing Ops9.1 M7.1 M7.7 M
Pretty Stable
Research Development79 K119.6 K67.2 K
Slightly volatile
Net Income Applicable To Common Shares9.2 M6.4 M7.6 M
Pretty Stable
Tax Provision2.4 M1.6 M3.8 M
Slightly volatile
Interest Income290.8 K488.8 K282.8 K
Slightly volatile
Reconciled Depreciation4.3 MM3.5 M
Slightly volatile

Biofil Chemicals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow357.2 K376 K1.8 M
Very volatile
Depreciation3.2 MM3.1 M
Slightly volatile
End Period Cash Flow24 M22.8 M4.9 M
Slightly volatile
Sale Purchase Of Stock13.7 M15.4 M16.8 M
Slightly volatile
Stock Based Compensation2.8 M3.2 M3.5 M
Slightly volatile

Biofil Fundamental Market Drivers

Cash And Short Term Investments22.8 M

About Biofil Chemicals Financial Statements

Biofil Chemicals stakeholders use historical fundamental indicators, such as Biofil Chemicals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Biofil Chemicals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biofil Chemicals' assets and liabilities are reflected in the revenues and expenses on Biofil Chemicals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biofil Chemicals Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 M1.5 M
Total Revenue400.4 M420.4 M
Cost Of Revenue387.8 M407.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Biofil Stock

Biofil Chemicals financial ratios help investors to determine whether Biofil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biofil with respect to the benefits of owning Biofil Chemicals security.